|Articles|May 1, 2004

Dermatology Life Quality Indexprovides different information from PASI

Washington - The Dermatology Life Quality Index (DLQI) is a widely used and validated measure of patient-reported outcomes in psoriasis. Unlike the Psoriasis Area Severity Index (PASI) score, a well-established measure of a patient's disease activity where each area of the body is weighted proportionally to the surface area covered, the DLQI is more heavily influenced by areas of the body that are readily visible, such as the head and lower extremities. "Therefore, the DLQI may provide information regarding outcomes beyond that described by the PASI score," said Alexa B. Kimball, M.D., M.P.H., assistant professor of dermatology at Stanford University.

Related to this article

TanPrevent and the Case for Preventing Thousands of Melanomas
Learn why indoor tanning remains a preventable source of melanoma, what research suggests about why some patients experience difficulty stopping, and how a clinical pilot called TanPrevent could connect education with follow-up support to help them quit and stay quit.
Journal Digest: November 16
Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.